Nicholas Brousseau1, Dominique Gagnon2, Maryline Vivion2, Vanessa Poliquin2, Isabelle Boucoiran2, Bruce Tapiéro2, Eve Dubé2. 1. Institut national de santé publique du Québec (Brousseau, Gagnon, Vivion, Dubé); Université Laval (Brousseau, Vivion, Dubé), Québec, Que.; Department of Obstetrics, Gynecology and Reproductive Sciences (Poliquin), University of Manitoba, Winnipeg, Man.; Centre hospitalier universitaire Sainte-Justine (Boucoiran, Tapiéro), Montréal, Que. nicholas.brousseau.ciussscn@ssss.gouv.qc.ca. 2. Institut national de santé publique du Québec (Brousseau, Gagnon, Vivion, Dubé); Université Laval (Brousseau, Vivion, Dubé), Québec, Que.; Department of Obstetrics, Gynecology and Reproductive Sciences (Poliquin), University of Manitoba, Winnipeg, Man.; Centre hospitalier universitaire Sainte-Justine (Boucoiran, Tapiéro), Montréal, Que.
Abstract
BACKGROUND: Vaccination of all pregnant women with an acellular pertussis-containing vaccine (tetanus, diphtheria, pertussis [Tdap]) was recently recommended in Canada, ideally between 27 and 32 weeks of gestation. This study aimed to describe the existing model of prenatal care in Quebec and determine to what extent maternal vaccination against pertussis could be integrated into this model. METHODS: In Quebec, health care is organized around Local Community Service Centres (LCSCs) that serve specific geographic areas. For each of 158 LCSCs (98.1% of LCSCs in the province), we invited 1 nurse or manager involved in prenatal care to participate in a cross-sectional Web-based survey. The structure of prenatal care visits and potential integration of maternal Tdap vaccination into the existing model were documented and compared according to urbanization level, determined with the use of census data. RESULTS: A completed survey was obtained for 127 LCSCs (response rate 80.4%). Only 13 (10.2%) and 14 (11.0%) LCSCs offered on-site visits with a nurse for the majority of pregnant women during the second and third trimesters, respectively. A significantly higher proportion of rural LCSCs than urban LCSCs offered on-site visits to pregnant women in the third trimester (13 [18%] v. 1 [2%]) (p = 0.003). In at least 50 LCSC service areas (39.4%), vaccines were not available in most medical clinics offering prenatal care. INTERPRETATION: Given the current situation in Quebec, implementing universal maternal Tdap vaccination may be challenging, which may result in suboptimal vaccine coverage among pregnant women. As other Canadian provinces may face similar issues, a priority will be to evaluate province-based implementation models to develop efficient ways to provide maternal Tdap vaccination across Canada. Copyright 2018, Joule Inc. or its licensors.
BACKGROUND: Vaccination of all pregnant women with an acellular pertussis-containing vaccine (tetanus, diphtheria, pertussis [Tdap]) was recently recommended in Canada, ideally between 27 and 32 weeks of gestation. This study aimed to describe the existing model of prenatal care in Quebec and determine to what extent maternal vaccination against pertussis could be integrated into this model. METHODS: In Quebec, health care is organized around Local Community Service Centres (LCSCs) that serve specific geographic areas. For each of 158 LCSCs (98.1% of LCSCs in the province), we invited 1 nurse or manager involved in prenatal care to participate in a cross-sectional Web-based survey. The structure of prenatal care visits and potential integration of maternal Tdap vaccination into the existing model were documented and compared according to urbanization level, determined with the use of census data. RESULTS: A completed survey was obtained for 127 LCSCs (response rate 80.4%). Only 13 (10.2%) and 14 (11.0%) LCSCs offered on-site visits with a nurse for the majority of pregnant women during the second and third trimesters, respectively. A significantly higher proportion of rural LCSCs than urban LCSCs offered on-site visits to pregnant women in the third trimester (13 [18%] v. 1 [2%]) (p = 0.003). In at least 50 LCSC service areas (39.4%), vaccines were not available in most medical clinics offering prenatal care. INTERPRETATION: Given the current situation in Quebec, implementing universal maternal Tdap vaccination may be challenging, which may result in suboptimal vaccine coverage among pregnant women. As other Canadian provinces may face similar issues, a priority will be to evaluate province-based implementation models to develop efficient ways to provide maternal Tdap vaccination across Canada. Copyright 2018, Joule Inc. or its licensors.
Authors: Elyse Olshen Kharbanda; Gabriela Vazquez-Benitez; Heather S Lipkind; Nicola P Klein; T Craig Cheetham; Allison L Naleway; Grace M Lee; Simon Hambidge; Michael L Jackson; Saad B Omer; Natalie McCarthy; James D Nordin Journal: Vaccine Date: 2016-01-04 Impact factor: 3.641
Authors: Stephen Kerr; Carla M Van Bennekom; Jennifer L Liang; Allen A Mitchell Journal: MMWR Morb Mortal Wkly Rep Date: 2017-10-20 Impact factor: 17.586
Authors: Eve Dubé; Dominique Gagnon; Kyla Kaminsky; Courtney R Green; Manale Ouakki; Julie A Bettinger; Nicholas Brousseau; Eliana Castillo; Natasha S Crowcroft; S Michelle Driedger; Devon Greyson; Deshayne Fell; William Fisher; Arnaud Gagneur; Maryse Guay; Donna Halperin; Scott A Halperin; Shannon MacDonald; Samantha B Meyer; Nancy M Waite; Kumanan Wilson; Holly O Witteman; Mark Yudin; Jocelynn L Cook Journal: Hum Vaccin Immunother Date: 2020-04-09 Impact factor: 3.452